Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Analogues of Fusaric (5-Butylpicolinic) Acid as Potent Inhibitors of Dopamine β-Hydroxylase

HIROYOSHI HIDAKA, TOMIKO ASANO and NOBUTAKA TAKEMOTO
Molecular Pharmacology March 1973, 9 (2) 172-177;
HIROYOSHI HIDAKA
Department of Biochemistry, Institute for Developmental Research, Aichi Prefecture Colony, Kasugai, Aichi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMIKO ASANO
Department of Biochemistry, Institute for Developmental Research, Aichi Prefecture Colony, Kasugai, Aichi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NOBUTAKA TAKEMOTO
Department of Biochemistry, Institute for Developmental Research, Aichi Prefecture Colony, Kasugai, Aichi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Several derivatives of picolinic acid were effective inhibitors of a purified bovine adrenal dopamine β-hydroxylase [3,4-dihydroxyphenylethylamine, ascorbate:oxygen oxidoreductase (hydroxylating), EC 1.14.2.1]. Inhibition of the enzyme by derivatives of picolinic acid was uncompetitive with the substrate and competitive with ascorbic acid. Among the derivatives of picolinic acid tested, 5-(3',4'-dihalobutyl)picolinic acid and 5-(3'-halobutyl) picolinic acid were the most potent inhibitors of the hydroxylase, producing 50% inhibition at a concentration of 10 nM. While 5-butylpicolinic acid seemed to have the highest stability constant of the copper chelate among the picolinic acids tested, its inhibitory activity was not the strongest. There was no correlation between the copper-chelating capacity of the picolinic acids and their inhibitory effects on the enzyme. Diethyldithiocarbamate, which is a more effective copper-chelating agent than 5-butylpicolinic acid was a less potent enzyme inhibitor. These data indicate that the inhibition of dopamine β-hydroxylase by picolinic acids was not primarily due to the chelate formation between the compounds and copper of the enzyme. Some of these picolinic acids seemed to be specific inhibitors of the hydroxylase and did not inhibit tyrosinase, a copper-containing enzyme, up to 10,000 times the concentration effectively inhibitory to dopamine β-hydroxylase.

ACKNOWLEDGMENTS The authors are grateful to Dr. I. Matsumoto and Dr. T. Miyano (Banyu Pharmaceutical Company, Ltd.) for help in preparing the picolinic acids. They also thank Dr. K. Suzuki (Department of Inorganic Chemistry, Faculty of Science, University of Nagoya) and Dr. K. Samejima (Department of Analytical Chemistry, Faculty of Pharmaceutical Science, University of Tokyo) for their helpful advice on the copper chelate study.

  • Copyright ©, 1973, by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 9, Issue 2
1 Mar 1973
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Analogues of Fusaric (5-Butylpicolinic) Acid as Potent Inhibitors of Dopamine β-Hydroxylase
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Analogues of Fusaric (5-Butylpicolinic) Acid as Potent Inhibitors of Dopamine β-Hydroxylase

HIROYOSHI HIDAKA, TOMIKO ASANO and NOBUTAKA TAKEMOTO
Molecular Pharmacology March 1, 1973, 9 (2) 172-177;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Analogues of Fusaric (5-Butylpicolinic) Acid as Potent Inhibitors of Dopamine β-Hydroxylase

HIROYOSHI HIDAKA, TOMIKO ASANO and NOBUTAKA TAKEMOTO
Molecular Pharmacology March 1, 1973, 9 (2) 172-177;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics